IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy. - Pagano F; Girone C; Borrelli F; Romaniello D; Gelfo V; Filippini DM; Morselli A; Mazzeschi M; Querzoli G; Ambrosi F; Miano C; D'Uva G; et al. (NPJ precision oncology, 2026)